Doug Brunk is a San Diego-based award-winning reporter who began covering health care in 1991. Before joining the company, he wrote for the health sciences division of Columbia University and was an associate editor at Contemporary Long Term Care magazine when it won a Jesse H. Neal Award. His work has been syndicated by the Los Angeles Times and he is the author of two books related to the University of Kentucky Wildcats men's basketball program. Doug has a master’s degree in magazine journalism from the S.I. Newhouse School of Public Communications at Syracuse University. Follow him on Twitter @dougbrunk.
News
FDA adds safety-related information to its dermal filler webpage
- Author:
- Doug Brunk
The update relates delayed-onset inflammation that has been reported to occur near filler treatment sites after viral or bacterial illnesses or...
News
New guidelines for MTX use in pediatric inflammatory skin disease unveiled
- Author:
- Doug Brunk
One of the recommendations states that liver biopsy is not indicated for routine monitoring of pediatric patients taking low-dose MTX.
News
Study points to need to improve identification of culprit in SJS/TEN cases
- Author:
- Doug Brunk
A single culprit drug was labeled in 17 cases, but physicians communicated certainty in only 7 of those cases.
News
Imaging techniques will revolutionize cancer detection, expert predicts
- Author:
- Doug Brunk
Jennifer Barton, PhD, and her colleagues are developing an OCT/fluorescence imaging falloposcope that is 0.8 mm in diameter, flexible, and...
News
Prognostic factors of SCCs in organ transplant recipients worse compared with general population
- Author:
- Doug Brunk
SCCs developed most frequently on the head/neck in organ transplant recipients and on the arms/hands in the general population.
News
Experts share their sun protection tips for children
- Author:
- Doug Brunk
Most sunscreens are not approved for use in children under the age of 6 months because testing has not been done in this age group, Dr. Adelaide A...
News
Report eyes complications from microwave energy devices for hyperhidrosis
- Author:
- Doug Brunk
The study authors recommend questioning patients about hidradenitis suppurativa (HS) history and examining for HS clinical findings before using...
News
How does psoriasis affect fertility and birth outcomes?
- Author:
- Doug Brunk
“The mechanism to link the higher risk of pregnancy loss in patients with psoriasis is not clear,” the authors wrote.
News
Lower racial disparity in melanoma diagnoses in vets than U.S. men overall, study finds
- Author:
- Doug Brunk
Melanoma was the fourth-most common cancer diagnosed in male VA patients.
News
Men underrepresented in clinical trials of laser hair removal, review finds
- Author:
- Doug Brunk
“Clinicians should emphasize inclusivity in future laser hair removal clinical trials and include outcomes by sex,” one of the investigators said...
News
Picosecond laser applications continue to expand
- Author:
- Doug Brunk
“In 2023, we’re better than we’ve ever been in terms of our ability to safely and effectively improve melasma,” Dr. Paul M. Friedman said.
News
Two phase 3 trials show benefits of dupilumab for prurigo nodularis
- Author:
- Doug Brunk
The results “support the involvement of type 2 cytokines in driving PN disease pathogenesis and the targeting of the IL-4/IL-13 axis as a novel...
News
1,726-nm lasers poised to revolutionize acne treatment, expert predicts
- Author:
- Doug Brunk
“Further study of both scarring and acne are needed to fully categorize the benefit and to optimize treatments,” Dr. Jeffrey Dover said.
News
Controlled hyperthermia: Novel treatment of BCCs without surgery continues to be refined
- Author:
- Doug Brunk
A novel, noninvasive technique of controlled hyperthermia and mapping protocol designed to help clinicians with margin assessment and treatment of...
News
Best practices document outlines genitourinary applications of lasers and energy-based devices
- Author:
- Doug Brunk
One research firm estimated that the global women’s health and wellness market is valued at more than $31 billion globally.